1. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  2. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  3. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  4. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  5. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  6. HRPP Guidance, Forms and Resources
  7. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  8. Clinical Trials Registration & Results Reporting
  9. Compliance Monitoring and Quality Improvement
  10. Human Subjects Research Protection Program (HRPP) Policy Index
  11. Research with Adult Participants Lacking Capacity to Consent
  12. Obtaining and Documenting Informed Consent
  13. Certificate of Confidentiality (CoC) Application Help
  14. UW Post-Approval Monitors
  15. UW HRPP Quality Assurance
  16. Exempt Research
  17. Quality Assurance Committees
  18. HRPP and IRB Resources
  19. Institutional Official in Charge of HRPP
  20. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  21. IRB Authority and Independence
  22. IRB Composition and Quality Performance
  23. Noncompliance
  24. Unanticipated Problems
  25. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  26. Suspension and Termination of Approved Research
  27. HRPP Education and Training
  28. Engagement in Human Participants Research at UW–Madison
  29. Initial Review: Submission and Review Policy
  30. IRB Meeting Minutes and Regulatory Documentation
  31. Principal Investigator Status for UW–Madison Studies Involving Human Participants
  32. IRB Members’ Conflicts of Interest
  33. UW–Madison Federalwide Assurance (FWA) & IRB Registration Numbers
  34. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  35. Review of Research Involving Vulnerable Participants
  36. Recruitment of Research Participants Guidance
  37. Instructions for Linking Previous CITI Training to Your NetID
  38. Good Clinical Practice (GCP) Training Guidance and Instructions
  39. Instructions for Completing CITI Human Participants Research Training
  40. Research Participants
  41. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  42. Post-Approval Monitoring Program
  43. Issues in Human Subjects Research When State Law May Apply
  44. Retention of IRB Records
  45. Continuing Review: Submission and Review
  46. Study Closure
  47. Contact Information for Reporting Suggestions and Concerns
  48. Changes in Research Activities: Submission and Review
  49. IRB Reliance
  50. HRPP Newsletter - Spring 2018
  51. Human Research Protection Program Newsletter
  52. Protecting Research Participants Privacy Interests and Confidentiality of Data
  53. Evaluating the Scientific or Scholarly Merits of Proposed Research
  54. Equitable Selection of Research Participants Guidance
  55. Instructions for Completing CITI Refresher Training
  56. Creation and Dissemination of Policies and Related Documentation
  57. De-Identified Publicly Available Datasets Guidance
  58. Reporting to Institutional and External Authorities
  59. Review of Data and Safety Monitoring in Research
  60. Maintenance of IRB Records
  61. ED/SBS IRB Principal Investigator Responsibilities
  62. Good Clinical Practice (GCP) Refresher Instructions
  63. Reportable Abuse and Neglect Guidance
  64. IRB Consultants Use and Conflict of Interest
  65. Common Rule (45 CFR 46)
  66. Use of Human Fetal Tissue in Research
  67. IRB Purview
  68. Student Research
  69. Developing an Internal Quality Assurance (QA) Program Guidance
  70. Exceptions to Informed Consent Requirements in Emergency Situations
  71. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  72. IRB Meetings
  73. UW-Madison HIPAA Program
  74. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  75. IRB Review of Study Resources
  76. Preventing Noncompliance Guidance
  77. Considerations for Accepting or Ceding IRB Review Guidance
  78. Expert Review
  79. Compliance with Human Research Protections in Sponsored Research
  80. Campus IT Policies
  81. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  82. IRB Analysis of Risks and Benefits of Research Guidance
  83. List of Approved De-Identified Publicly Available Datasets
  84. NIH Genomic Data Sharing Policy for Human Data Guidance
  85. Conflicts of Interest of Non-UW-Madison Key Personnel
  86. FDA IRB Regulations (21 CFR 56)
  87. Monitoring the Consent Process
  88. Use of Human Fetal Tissue in Research Policy Links
  89. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  90. Post Approval Monitoring Program Services
  91. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  92. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  93. Human Research Protection Program (HRPP) Newsletter - Spring 2016
  94. UW Human Research Protection Program Newsletter - Fall 2015